PD 173638
Latest Information Update: 19 Oct 2000
At a glance
- Originator Pfizer
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 19 Oct 2000 No-Development-Reported for HIV-1 infections in USA (Unknown route)
- 21 Jun 2000 Warner-Lambert has merged with Pfizer
- 23 Jan 1998 New profile